Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
Tollemar
J
J
Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Ringdén
O
O
Heimdahl
A
A
Lönnqvist
B
B
Sundberg
B
B
D000208:Acute Disease; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D009059:Mouth Diseases / Q000150:complications; D009894:Opportunistic Infections / Q000150:complications; D018805:Sepsis / Q000150:complications
D003524:Cyclosporins; D006680:HLA Antigens; D008727:Methotrexate